Hard-to-Target WNT Pathway Gets a Fresh Look in Oncology
Rationale for targeting the Wnt signalling modulator Dickkopf‐1 for oncology - Kagey - 2017 - British Journal of Pharmacology - Wiley Online Library
Targeting the Wnt/beta-catenin pathway in cancer: Update on effectors and inhibitors. - Abstract - Europe PMC
Dkk (Dickkopf) Proteins | Arteriosclerosis, Thrombosis, and Vascular Biology
DKN-01 - Leap Therapeutics, Inc.
DKN-01 - Leap Therapeutics, Inc.
Resources - BeiGene Medical Europe
10-K 1 a2234497z10-k.htm 10-K Use these links to rapidly review the document TABLE OF CONTENTS PART III INDEX TO CONSOLIDATED FINANCIAL STATEMENTS Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION ...
Targeting the Versatile Wnt/β-Catenin Pathway in Cancer Biology and Therapeutics: From Concept to Actionable Strategy | OMICS: A Journal of Integrative Biology
Functional studies of DKK1 variants present in the general population - Revista de Osteoporosis y Metabolismo Mineral · Publicación Oficial SEIOMM
Frontiers | Dickkopf-1: A Promising Target for Cancer Immunotherapy | Immunology
Expression and Role of Dickkopf-1 (Dkk1) in Tumors: From the Cells to | CMAR
Carboxylesterase Notum Is a Druggable Target to Modulate Wnt Signaling | Journal of Medicinal Chemistry
Dkk (Dickkopf) Proteins | Arteriosclerosis, Thrombosis, and Vascular Biology
Targeting the Wnt/beta-catenin pathway in cancer: Update on effectors and inhibitors - Cancer Treatment Reviews
The Wnt signaling pathway: a potential therapeutic target against cancer - Ghosh - 2019 - Annals of the New York Academy of Sciences - Wiley Online Library
DKN-01 Offers a Solution to Modest IO Benefit in Advanced Gastroesophageal Carcinoma
Cancers | Free Full-Text | A Review of the Role of Wnt in Cancer Immunomodulation | HTML
Overexpression of β-catenin and downregulation of Dkk1 abolishes the... | Download Scientific Diagram
Wnt/beta-catenin pathway: modulating anticancer immune response | Journal of Hematology & Oncology | Full Text
Frontiers | Dickkopf-1: A Promising Target for Cancer Immunotherapy | Immunology
Frontiers | Drug Discovery of DKK1 Inhibitors | Pharmacology
10-K 1 a2234497z10-k.htm 10-K Use these links to rapidly review the document TABLE OF CONTENTS PART III INDEX TO CONSOLIDATED FINANCIAL STATEMENTS Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION ...
Molecular genetics and targeted therapy of WNT-related human diseases (Review)
Therapeutic molecules that target Wnt signaling pathway at the level... | Download Scientific Diagram
